Advertisement
FOCL vs MCK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCL is a Hold and MCK is a Hold.
FOCL's Stochastic Oscillator stays in oversold zone for 6 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FOCL's RSI Oscillator exited the oversold zone, 27 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
Following a +4.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where FOCL advanced for three days, in 184 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FOCL as a result. In 69 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for FOCL turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 34 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
FOCL broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for FOCL entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. FOCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.472) is normal, around the industry mean (2.488). FOCL has a moderately high P/E Ratio (100.000) as compared to the industry average of (39.020). FOCL's Projected Growth (PEG Ratio) (8.100) is very high in comparison to the industry average of (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (1.919) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
MCK in upward trend: 10-day moving average moved above 50-day moving average on October 05, 2026
The 10-day moving average for MCK crossed bullishly above the 50-day moving average on October 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on MCK as a result. In 54 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MCK just turned positive on October 05, 2026. Looking at past instances where MCK's MACD turned positive, the stock continued to rise in 34 of 53 cases over the following month. The odds of a continued upward trend are 64%.
MCK moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in 256 of 385 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
MCK broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MCK entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MCK's P/B Ratio (-59.961) is very low in comparison to the industry average of (2.488). P/E Ratio (22.969) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (1.616) is also within normal values, averaging (2.016). Dividend Yield (0.004) settles around the average of (0.004) among similar stocks. P/S Ratio (0.265) is also within normal values, averaging (4.260).
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
FOCL | MCK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 11 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 40 | 27 | |
P/E GROWTH RATING 1..100 | 99 | 70 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCK's Valuation (12) in the Medical Distributors industry is significantly better than the same rating for FOCL (100) in the Biotechnology industry. This means that MCK’s stock grew significantly faster than FOCL’s over the last 12 months.
MCK's Profit vs Risk Rating (11) in the Medical Distributors industry is significantly better than the same rating for FOCL (100) in the Biotechnology industry. This means that MCK’s stock grew significantly faster than FOCL’s over the last 12 months.
MCK's SMR Rating (100) in the Medical Distributors industry is in the same range as FOCL (100) in the Biotechnology industry. This means that MCK’s stock grew similarly to FOCL’s over the last 12 months.
MCK's Price Growth Rating (27) in the Medical Distributors industry is in the same range as FOCL (40) in the Biotechnology industry. This means that MCK’s stock grew similarly to FOCL’s over the last 12 months.
MCK's P/E Growth Rating (70) in the Medical Distributors industry is in the same range as FOCL (99) in the Biotechnology industry. This means that MCK’s stock grew similarly to FOCL’s over the last 12 months.
| FOCL | MCK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 44% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 40% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 64% |
| TrendWeek ODDS (%) | 2 days ago 84% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 70% |
| Advances ODDS (%) | 3 days ago 76% | 2 days ago 66% |
| Declines ODDS (%) | 7 days ago 85% | 17 days ago 42% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 41% |
| Aroon ODDS (%) | 2 days ago 88% | 2 days ago 37% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FOCL’s FA Score shows that 0 FA rating(s) are green while MCK’s FA Score has 3 green FA rating(s).
- FOCL’s FA Score: 0 green, 5 red.
- MCK’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FOCL’s TA Score shows that 3 TA indicator(s) are bullish while MCK’s TA Score has 5 bullish TA indicator(s).
- FOCL’s TA Score: 3 bullish, 5 bearish.
- MCK’s TA Score: 5 bullish, 5 bearish.
Price Growth
FOCL (@Medical Distributors) experienced а -1.64% price change this week, while MCK (@Medical Distributors) price change was +4.36% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.67%. For the same industry, the average monthly price growth was +3.33%, and the average quarterly price growth was -20.54%.
Reported Earning Dates
MCK is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Medical Distributors (+1.67% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDXD | 22.71 | 1.04 | +4.80% |
| MicroSectors Gold Miners - 3X Inverse Leveraged ETNs (GDXD) | |||
| TXUE | 34.70 | 0.17 | +0.48% |
| Thornburg International Equity ETF (TXUE) | |||
| MYCM | 23.49 | N/A | N/A |
| State Street My2033 Corporate Bond ETF (MYCM) | |||
| SUSA | 158.62 | -0.07 | -0.04% |
| iShares ESG Optimized MSCI USA ETF (SUSA) | |||
| PSCX | 33.76 | -0.02 | -0.04% |
| Pacer Swan SOS Conservative (January) ETF (PSCX) | |||
MCK and
Correlation & Price change
A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.
| Ticker / NAME | Correlation To MCK | 1D Price Change % | ||
|---|---|---|---|---|
| MCK | 100% | +0.64% | ||
| COR - MCK | 71% Closely correlated | +1.55% | ||
| CAH - MCK | 66% Closely correlated | +0.69% | ||
| HSIC - MCK | 12% Poorly correlated | +0.95% | ||
| HKPD - MCK | 10% Poorly correlated | -1.59% | ||
| FOCL - MCK | 8% Poorly correlated | -2.33% | ||
More | ||||